Keyword: Strides Pharma Science
HiFiBiO raises $67 million in series C. Kyowa Kirin wins long-awaited FDA nod for Parkinson's drug Nourianz. SEBI's initial probe clears Sun Pharma.
Strides Pharma has picked up a soft gel manufacturing facility in the U.S. from Micelle BioPharma for very little but intends to invest in it.
Takeda's quarterly margin hits 32.4%; the FDA slaps a Dr. Reddy's API plant with a Form 483; Strides Pharma enters China through a joint venture.
Takeda sells €1.5 billion European drugs; top Indian drugmakers expand in China; Eisai moves closer to a quick Alzheimer’s blood test.
The FDA lambasted Strides Pharma in a warning letter after inspectors found testing records in the trash and in bags by a shredder.